Applied Filters
Scientists want CRISPR regulation amid reports of foetus gene-editing
Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins.
CRISPR tech market to reach $1.72m by 2023: report
The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.
Life sciences partners join Saul Ewing’s Boston office
Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds.
10x Genomics sued over cell research tools
Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.
CRISPR Therapeutics expands MaxCyte partnership into immuno-oncology
Gene-editing company CRISPR Therapeutics has expanded its partnership with US-based MaxCyte, which focuses on cell-based medicines, into the immuno-oncology arena.
BMS company not required to pay damages in trade secrets case
A jury has said that Flexus Biosciences, a company owned by Bristol-Myers Squibb, does not need to pay damages despite being liable for trade secrets misappropriation.
HGF hires former Roivant Sciences VP
HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner.
Illumina buys rival Pacific Biosciences for $1.2bn
Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences for $1.2 billion.
ERS Genomics licenses CRISPR patents to Cambridge University spin-out
The company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, ERS Genomics, has signed a patent licensing deal with DefiniGEN, a spin-out from the University of Cambridge, UK.
Nelson Mullins adds life sciences litigator in NYC
Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel.
